Dementias and neurodegeneration (DenDRoN)
The Dementias and neurodegeneration (DeNDRoN) Specialty is one of 30 Specialties which bring together communities of clinical practice to provide national networks of research expertise. Our membership is made up of research-interested clinicians and practitioners at both national and local levels. Our job is to ensure that studies into dementia and neurodegeneration (including Parkinson’s disease, Alzheimer’s Disease, Motor Neurone Disease and Huntington’s disease) that are included in our national portfolio of research receive the right support to make sure they are delivered successfully in the NHS.
Follow us on @nihrcrndementia.
About Dementias and neurodegeneration research
The Clinical Research Network: Dementias and neurodegeneration (DeNDRoN) supports the set up and delivery of clinical research in the NHS in a range of diseases including dementias, Parkinson’s disease, motor neurone disease and Huntington’s disease.
These diseases are increasingly understood to have commonalities in underlying mechanisms, patient experience, and symptoms; and their management is increasingly multi-disciplinary and converging over time. Advances in understanding of these diseases and new treatments are likely to come from inter-disciplinary research between them.
Patient, Carer and Public Information
We invite patients, carers and anyone affected by dementia and other neurodegenerative diseases to have a say on research matters. There are many ways that you can be involved in research; from participating in a study to helping to shape the direction of research by sharing your experiences or offering your opinion on research ideas.
Lucy Norman and her husband Angus share their experience of taking part in Parkinson's Disease research.
Stephen Roberts talks about his experience of taking part in Parkinson's Disease research.
Last year, DeNDRoN (Dementias & neurodegeneration speciality) supported a study sponsored by University of Manchester titled ‘SAVE-D’ (South Asian Voices Enabling Dementia Care). This study looked at the challenges that South Asians in Greater Manchester faced, when presented with recognising and addressing memory problems and dementia.
The Dementias and neurodegeneration (DeNDRoN) Specialty recently assisted the team working on the Parkinson’s Disease (PD) COMM study, a pilot project looking at the cost-effectiveness of different speech and language therapy treatments for people with Parkinson's Disease.
Enquiries from the life-sciences industry
General Enquiries - DeNDRoN
27 Old Gloucester Street
C/O Box 81
Existing Portfolio enquiries
Enquiries about existing studies on the NIHR CRN Portfolio
New portfolio enquiries
Initial enquiries about the NIHR CRN Portfolio